D.A. Davidson & CO. boosted its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 30.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,715 shares of the semiconductor company’s stock after buying an additional 1,346 shares during the period. D.A. Davidson & CO.’s holdings in Synopsys were worth $2,820,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Lionshead Wealth Management LLC lifted its stake in shares of Synopsys by 1.9% in the 2nd quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock valued at $469,000 after purchasing an additional 17 shares during the period. YANKCOM Partnership grew its stake in shares of Synopsys by 3.3% during the second quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after purchasing an additional 17 shares during the period. Manchester Capital Management LLC increased its holdings in Synopsys by 5.3% in the second quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock valued at $174,000 after purchasing an additional 17 shares during the last quarter. Hemington Wealth Management lifted its stake in Synopsys by 10.1% in the second quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after buying an additional 18 shares during the period. Finally, Concord Asset Management LLC VA boosted its holdings in Synopsys by 0.8% during the second quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock worth $1,220,000 after buying an additional 18 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Trading Down 1.0%
Shares of NASDAQ:SNPS opened at $514.49 on Friday. The firm has a market cap of $98.43 billion, a price-to-earnings ratio of 64.39, a PEG ratio of 4.32 and a beta of 1.12. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company’s fifty day simple moving average is $443.64 and its 200 day simple moving average is $504.01. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48.
Insider Buying and Selling
In other news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Janet Lee sold 250 shares of the stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $510.00, for a total transaction of $127,500.00. Following the transaction, the insider owned 12,209 shares of the company’s stock, valued at $6,226,590. The trade was a 2.01% decrease in their position. The SEC filing for this sale provides additional information. 0.62% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of analysts have recently commented on SNPS shares. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Wells Fargo & Company upped their target price on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research note on Thursday, December 11th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Morgan Stanley boosted their price target on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Finally, Mizuho lowered their price objective on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a research report on Thursday, September 11th. Eleven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Synopsys currently has an average rating of “Moderate Buy” and a consensus price target of $562.13.
View Our Latest Research Report on SNPS
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
